Roche Holding AG (RHHBF)
OTCMKTS
· Delayed Price · Currency is USD
436.00
-29.00 (-6.24%)
Mar 9, 2026, 10:39 AM EST
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,849
Profits / Employee
$157,320
Market Cap
350.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 68 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
| Tian'an Technology Group | 8 |
| Vaxart | 105 |
Roche Holding AG News
- 2 hours ago - Roche Tumbles, Taking Olema With It, On A High-Profile Failure - Investor's Business Daily
- 5 hours ago - Roche's Breast Cancer Drug Falls Short In Phase 3 Study - Benzinga
- 5 hours ago - Roche (RHHBY) Shares Drop After Breast Cancer Drug Trial Misses Goal - GuruFocus
- 6 hours ago - Roche Shares Drop Up to 7.5% After Breast Cancer Pill Misses Trial Goal - GuruFocus
- 8 hours ago - Roche shares drop as oral breast cancer drug fails in trial - Reuters
- 11 hours ago - Genentech: PersevERA Breast Cancer Study Fails To Meet Primary Objective - Nasdaq
- 11 hours ago - Roche Breast-Cancer Treatment Falls Short of Primary Goal in Late-Stage Study - WSJ
- 11 hours ago - Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer - Business Wire